Qualigen therapeutics completes recertification of existing as1411 drug supply for use in upcoming clinical trials

Carlsbad, calif., dec. 2, 2020 /prnewswire/ -- qualigen therapeutics, inc. (nasdaq: qlgn) announces that it has completed the recertification of its supply of as1411, and has begun final formulation and filling for use in the company's proposed phase 2a efficacy trials of as1411 for the...
QLGN Ratings Summary
QLGN Quant Ranking